Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 944.40
+6.25 (0.67%)
At close: Oct 16, 2026
Jubilant Pharmova Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 149,581 | 129,323 | 141,360 | 90,432 | 44,418 | 61,740 | |
Market Cap Growth | -12.16% | -8.52% | 56.32% | 103.60% | -28.06% | -43.03% |
Enterprise Value | 173,085 | 151,721 | 161,255 | 117,283 | 70,881 | 82,624 |
Last Close Price | 944.40 | 812.25 | 884.32 | 559.92 | 271.44 | 371.84 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 42.60 | 32.45 | 16.84 | 117.29 | - | 14.92 |
Forward PE | 28.01 | 24.10 | 24.94 | 14.22 | 9.99 | 11.22 |
PS Ratio | 1.74 | 1.56 | 1.95 | 1.35 | 0.71 | 1.01 |
PB Ratio | 2.11 | 1.82 | 2.27 | 1.67 | 0.82 | 1.16 |
P/TBV Ratio | 5.00 | 4.33 | 5.40 | 4.69 | 2.20 | 2.87 |
P/FCF Ratio | - | - | - | 122.87 | - | 25.99 |
P/OCF Ratio | 12.19 | 10.54 | 13.19 | 9.31 | 6.72 | 7.37 |
PEG Ratio | - | 0.20 | 0.28 | 0.95 | 0.88 | 1.35 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.01 | 1.83 | 2.23 | 1.75 | 1.13 | 1.35 |
EV/EBITDA Ratio | 15.32 | 13.53 | 15.34 | 14.78 | 10.97 | 7.75 |
EV/EBIT Ratio | 23.13 | 18.52 | 19.99 | 22.42 | 18.91 | 9.84 |
EV/FCF Ratio | - | - | - | 159.35 | - | 34.78 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.51 | 0.51 | 0.44 | 0.68 | 0.68 | 0.60 |
Debt / EBITDA Ratio | 3.20 | 3.05 | 2.45 | 4.31 | 5.18 | 2.82 |
Debt / FCF Ratio | - | - | - | 49.78 | - | 13.44 |
Net Debt / Equity Ratio | 0.33 | 0.33 | 0.26 | 0.50 | 0.49 | 0.41 |
Net Debt / EBITDA Ratio | 2.20 | 2.09 | 1.56 | 3.41 | 4.12 | 2.07 |
Net Debt / FCF Ratio | - | -10.56 | -37.76 | 36.79 | -17.31 | 9.27 |
Asset Turnover | - | 0.59 | 0.60 | 0.59 | 0.59 | 0.65 |
Inventory Turnover | - | 2.40 | 2.07 | 1.73 | 1.54 | 1.23 |
Quick Ratio | - | 1.07 | 1.03 | 1.18 | 1.26 | 1.34 |
Current Ratio | - | 1.62 | 1.65 | 2.05 | 2.12 | 2.21 |
Return on Equity (ROE) | - | 5.96% | 14.34% | 1.34% | -1.21% | 8.21% |
Return on Assets (ROA) | - | 3.62% | 4.15% | 2.88% | 2.22% | 5.55% |
Return on Invested Capital (ROIC) | 5.10% | 6.12% | 8.60% | 2.76% | -11.24% | 7.64% |
Return on Capital Employed (ROCE) | - | 6.30% | 7.60% | 5.40% | 4.00% | 10.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.35% | 3.08% | 5.94% | 0.85% | -1.37% | 6.70% |
FCF Yield | -1.49% | -1.72% | -0.31% | 0.81% | -3.46% | 3.85% |
Dividend Yield | 0.53% | 0.61% | 0.56% | 0.88% | 1.79% | 1.29% |
Payout Ratio | 22.55% | 19.95% | 9.48% | 103.50% | - | 19.34% |
Buyback Yield / Dilution | 0.04% | -0.01% | -0.01% | 0.18% | 0.02% | 0.06% |
Total Shareholder Return | 0.57% | 0.60% | 0.55% | 1.06% | 1.81% | 1.35% |